Crossmark

Heterogeneity of triple negative breast cancer: Current advances in subtyping and treatment implications

Published Online: 2022-09-01

Authors

Asleh, Karama http://orcid.org/0000-0002-2873-7253
Riaz, Nazia

Nielsen, Torsten O.
License Information

Text and Data Mining valid from 2022-09-01

Version of Record valid from 2022-09-01
More Information

Article History

Received: 3 June 2022

Accepted: 25 August 2022

First Online: 1 September 2022

Declarations

:

: Not applicable.

: Not applicable.

: Torsten O. Nielsen (T.O.N.) received royalty from NanoString Technologies and Veracyte outside the submitted work. T.O.N. has intellectual property rights and holds patent with Bioclassifier LLC. There is no conflict of interest for the other authors.

Document is current